Bronchiectasis and COVID-19 infection: a two-way street
10.1097/CM9.0000000000002447
- VernacularTitle:Bronchiectasis and COVID-19 infection: a two-way street
- Author:
Grace OSCULLO
1
;
Daniel Jose GÓMEZ-OLIVAS
;
Thais BEAUPERTHUY
;
Amina BEKKI
;
Alberto GARCIA-ORTEGA
;
Gabriella Maria MATERA
;
Mario CAZZOLA
;
Angel Miguel MARTINEZ-GARCIA
Author Information
1. Department of Pneumology, Hospital Universitario y Politécnico la Fe de Valencia, Valencia 46012, Spain
- Keywords:
Bronchiectasis;
Coronavirus;
COVID-19;
SARS-CoV-2
- From:
Chinese Medical Journal
2022;135(20):2398-2404
- CountryChina
- Language:Chinese
-
Abstract:
Bronchiectasis (BE) has been linked to past viral infections such as influenza, measles, or adenovirus. Two years ago, a new pandemic viral infection severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) broke out and it still persists today, and a significant proportion of surviving patients have radiological and clinical sequelae, including BE. Our aim was to thoroughly review the information available in the literature on the bidirectional relationship between SARS-CoV-2 infection and the development of BE, as well as the impact of this infection on patients already suffering from BE. Available information indicates that only a small percentage of patients in the acute phase of coronavirus disease 2019 (COVID-19) pneumonia develop BE, although the latter is recognized as one of the radiological sequelae of COVID-19 pneumonia, especially when it is caused by traction. The severity of the initial pneumonia is the main risk factor for the development of future BE, but during the COVID-19 pandemic, exacerbations in BE patients were reduced by approximately 50%. Finally, the impact of BE on the prognosis of patients with COVID-19 pneumonia is not yet known.
